Evidence map›Paper›PMID 38600607›Full record

Trial reportArthritis research & therapy2024

Usability and preliminary effectiveness of an app-based physical activity and education program for people with hip or knee osteoarthritis - a pilot randomized controlled trial.

F Weber, C Kloek, S Stuhrmann, Y Blum, C Grüneberg, C Veenhof

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Arthritis research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

F WeberDepartment of Applied Health Sciences, Division of Physiotherapy, Hochschule für Gesundheit, University of Applied Health Sciences, Gesundheitscampus 6-8, Bochum, 44801, Germany. franziska.weber@hs-gesundheit.de.
C KloekResearch Group Innovation of Human Movement Care, Knowledge Centre Healthy and Sustainable Living, HU University of Applied Sciences, Utrecht, The Netherlands.
S StuhrmannDepartment of Applied Health Sciences, Division of Physiotherapy, Hochschule für Gesundheit, University of Applied Health Sciences, Gesundheitscampus 6-8, Bochum, 44801, Germany.
Y BlumDepartment of Applied Health Sciences, Division of Physiotherapy, Hochschule für Gesundheit, University of Applied Health Sciences, Gesundheitscampus 6-8, Bochum, 44801, Germany.
C GrünebergDepartment of Applied Health Sciences, Division of Physiotherapy, Hochschule für Gesundheit, University of Applied Health Sciences, Gesundheitscampus 6-8, Bochum, 44801, Germany.
C VeenhofDepartment of Rehabilitation, Physiotherapy Science & Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHip and knee osteoarthritis (OA) are highly prevalent worldwide. The guidelines recommend physical activity and education as the core treatments for osteoarthritis. Digital health has the potential to engage people in physical activity and disease management. Therefore, we conducted a pilot trial to assess the usability and preliminary effectiveness of an app-based physical activity and education program (Join2Move) compared to usual care for people with hip and/or knee OA in Germany.

methodsA randomized controlled pilot study was conducted. Individuals with diagnosed or self-reported knee and hip OA were included. Allocation to the intervention or control group was randomized. The intervention group received the Join2Move program. The Join2Move program was previously developed as a website and evaluated in the Netherlands. For the current study, the program was translated and adapted to the German context and adjusted from a website to an app. The control group received usual care. The primary outcomes were usability and preliminary effectiveness (pain and physical functioning). Measurements were taken at baseline and at twelve weeks. The data analysis was performed using SPSS (IBM SPSS Statistics 29.0).

resultsSixty participants, with a mean age of 61.9 (SD ± 7.2) years, were allocated to the intervention (n = 32) or the control group (n = 28) and included in the analysis. The majority of participants had knee OA (68%), and 12% had hip and knee OA. The dropout rate was n = 11 (18%). No adverse events were reported. Usability was rated as acceptable (mean System Usability Scale = 71.3/100) with a wide range (32.5 to 100). Statistically significant between-group differences were found only for pain (mean difference 8.52 (95% CI 1.01 to 16.04), p = 0.027).

conclusionsJoin2Move demonstrated acceptable usability. The preliminary results of the pilot trial indicate the potential of a stand-alone app for the treatment of patients with hip or knee OA. However, the acceptable usability of Join2Move limits its recommendation for everyone. There appears to be room for improvement in app usability and in identifying patients for whom the app is suitable and the right time to use a stand-alone app.

trial registrationGerman Clinical Trials Register DRKS00027164 .

Indexed as

Mobile ApplicationsOsteoarthritis, HipOsteoarthritis, KneeAgedExerciseExercise TherapyHumansMiddle AgedPainPilot ProjectsQuality of LifeDigital healthEducationExerciseOsteoarthritisPhysical activityPilot study

Identifiers

PMID38600607
PMCPMC11005282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.